NCT01997047

Brief Summary

Pneumonia is the commonest cause of death in children worldwide, killing 1.5 million children under the age of 5 years, every year. This is more than the number of children dying from AIDS, malaria and tuberculosis combined. The current diagnostic and management protocols for managing serious respiratory diseases in children are 30 years old and are greatly in need of updating. The successful establishment of useful clinical management criteria for children with respiratory diseases will have benefits for children in low resource regions around the world. The goals of the study are:

  • To determine if children with respiratory distress can be reliably diagnosed under low-resource conditions.
  • To identify the clinical tests that best differentiate pneumonia from wheezy diseases. These will be used to establish updated diagnostic criteria for common pediatric lung diseases that broaden the current pneumonia algorithm by adding another for wheezy illnesses.
  • The ultimate objective is to improve the management and outcome of acute respiratory conditions in children.
  • Investigators also wish to test the efficacy of a locally developed cell phone oximeter probe in a low resource setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
502

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2013

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 27, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

September 21, 2017

Status Verified

September 1, 2017

Enrollment Period

1.5 years

First QC Date

May 29, 2013

Last Update Submit

September 19, 2017

Conditions

Keywords

Pneumoniabronchiolitisasthmachildrentachypneadeveloping countriesdiagnostic criteria

Outcome Measures

Primary Outcomes (1)

  • Child's diagnosis in one of four categories (pneumonia, wheezy disease, mixed and non-respiratory)

    All children enrolled in the study, fulfill WHO criteria for pneumonia on day one. After assessing 29 different variables at presentation (day 1), including CXR, oximetry, pulse, respiratory rate, a qualified pediatrician makes the primary study diagnosis on day 4. Based on the results and review of progress, the consultant places the child into one of four diagnostic groups - pneumonia, wheezy disease, mixed and non-respiratory. These are the principal reference diagnoses for the rest of the analyses.

    One year

Secondary Outcomes (1)

  • Child's clinical outcome in three categories (better, worse, dead)

    One year

Other Outcomes (1)

  • Child's oxygen saturation measured by cell-phone oximeter and bedside Massimo commercial oximeter

    one year

Study Arms (1)

Tachypneic children

All tachypneic children under 5 yrs age presenting to study centres. No exclusions.

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study is intended to clinically relevant. All tachypneic children below 5 yrs age are eligible for enrollment. There are no exclusion criteria. Sampling will be by convenience.

You may qualify if:

  • All children below 5 exceeding WHO age-dependent tachypnea criteria.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC's Children's Hospital

Vancouver, British Columbia, V6H 3V4, Canada

Location

MeSH Terms

Conditions

PneumoniaBronchiolitisAsthmaTachypnea

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesBronchitisBronchial DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael D Seear, FRCPC

    BC's Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

May 29, 2013

First Posted

November 27, 2013

Study Start

October 1, 2012

Primary Completion

April 1, 2014

Study Completion

October 1, 2014

Last Updated

September 21, 2017

Record last verified: 2017-09

Locations